Phase I Study of ALT-801 in Metastatic Melanoma/Kidney Cancer Patients

$201,603R01FY2009FDFDA

H. Lee Moffitt Cancer Ctr & Res Inst, Tampa FL

Investigators

Mayer Fishmancontact

View original record on NIH RePORTER →

Phase I Study of ALT-801 in Metastatic Melanoma/Kidney Cancer Patients · GrantIndex